Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford
Condition(s):Non Hodgkin LymphomaLast Updated:January 11, 2024Not yet recruiting